Global Oncolytic Virus Therapy Market 2020 by Company, Regions, Type and Application, Forecast to 2025
- ID:PD024926
- September 2020
- GIR (Global Info Research)
Single User License: $3,480.00
Multi User License: $5,220.00
Enterprise License: $6,960.00
The Global Oncolytic Virus Therapy Market Report is equipped with market data from 2015 to 2025. The report gives a covering key drivers and risks factors. The report is bifurcated by top global manufactures mentioning sales, revenue and prices as applicable. It also evaluates the competitive scenario of the leading players. The report expands to cover regional market data along with type and application. The report forecasts sales and revenue from 2020 to 2025. The detailed sales channel is also covered in the study.
The Oncolytic Virus Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Oncolytic Virus Therapy market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 23.8%% in the forecast period of 2020 to 2025 and will expected to reach USD 9 million by 2025, from USD 4 million in 2019.
Market segmentation
Oncolytic Virus Therapy market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Oncolytic Virus Therapy market has been segmented into:
By Application, Oncolytic Virus Therapy has been segmented into:
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Oncolytic Virus Therapy market presented in the report. This section sheds light on the sales growth of different regional and country-level Oncolytic Virus Therapy markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Oncolytic Virus Therapy market.
The report offers in-depth assessment of the growth and other aspects of the Oncolytic Virus Therapy market in important countries (regions), including:
Competitive Landscape and Oncolytic Virus Therapy Market Share Analysis
Oncolytic Virus Therapy competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Oncolytic Virus Therapy sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Oncolytic Virus Therapy sales, revenue and market share for each player covered in this report.
The major players covered in Oncolytic Virus Therapy are:
Among other players domestic and global, Oncolytic Virus Therapy market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately.
There are 14 Chapters to deeply display the Global Oncolytic Virus Therapy market.
1 Oncolytic Virus Therapy Market Overview
2 Company Profiles
3 Market Competition by Players
4 Market Size by Regions
5 North America Oncolytic Virus Therapy Revenue by Countries
6 Europe Oncolytic Virus Therapy Revenue by Countries
7 Asia-Pacific Oncolytic Virus Therapy Revenue by Countries
8 South America Oncolytic Virus Therapy Revenue by Countries
9 Middle East & Africa Revenue Oncolytic Virus Therapy by Countries
10 Market Size Segment by Type
11 Global Oncolytic Virus Therapy Market Segment by Application
12 Global Oncolytic Virus Therapy Market Size Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
The Oncolytic Virus Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Oncolytic Virus Therapy market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 23.8%% in the forecast period of 2020 to 2025 and will expected to reach USD 9 million by 2025, from USD 4 million in 2019.
Market segmentation
Oncolytic Virus Therapy market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Oncolytic Virus Therapy market has been segmented into:
- HSV-based Oncolytic Viruses
- Adenoviruses-based Oncolytic Viruses
- Vaccinia Virus-based Oncolytic Viruses
- Vesicular Stomatitis Virus-based Oncolytic Viruses
- Newcastle Disease Virus-based Oncolytic Viruses
By Application, Oncolytic Virus Therapy has been segmented into:
- Melanoma
- Prostate Cancer
- Breast Cancer
- Ovarian Cancer
- Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Oncolytic Virus Therapy market presented in the report. This section sheds light on the sales growth of different regional and country-level Oncolytic Virus Therapy markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Oncolytic Virus Therapy market.
The report offers in-depth assessment of the growth and other aspects of the Oncolytic Virus Therapy market in important countries (regions), including:
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
- South America (Brazil, Argentina, Colombia)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Oncolytic Virus Therapy Market Share Analysis
Oncolytic Virus Therapy competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Oncolytic Virus Therapy sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Oncolytic Virus Therapy sales, revenue and market share for each player covered in this report.
The major players covered in Oncolytic Virus Therapy are:
- Amgen
- SillaJen Biotherapeutics
- Transgene SA
- Oncolytics Biotech
- PsiOxus Therapeutics
- Viralytics
- Lokon Pharma
- Targovax
- Oncolys BioPharma
- Sorrento Therapeutics
- Genelux Corporation
- Cold Genesys
- Vyriad
- TILT Biotherapeutics
Among other players domestic and global, Oncolytic Virus Therapy market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately.
There are 14 Chapters to deeply display the Global Oncolytic Virus Therapy market.
1 Oncolytic Virus Therapy Market Overview
2 Company Profiles
3 Market Competition by Players
4 Market Size by Regions
5 North America Oncolytic Virus Therapy Revenue by Countries
6 Europe Oncolytic Virus Therapy Revenue by Countries
7 Asia-Pacific Oncolytic Virus Therapy Revenue by Countries
8 South America Oncolytic Virus Therapy Revenue by Countries
9 Middle East & Africa Revenue Oncolytic Virus Therapy by Countries
10 Market Size Segment by Type
11 Global Oncolytic Virus Therapy Market Segment by Application
12 Global Oncolytic Virus Therapy Market Size Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
Table of Contents
1 Oncolytic Virus Therapy Market Overview
1.1 Product Overview and Scope of Oncolytic Virus Therapy
1.2 Classification of Oncolytic Virus Therapy by Type
1.2.1 Global Oncolytic Virus Therapy Revenue by Type
1.2.2 Global Oncolytic Virus Therapy Revenue Market Share by Type in 2019
1.2.3 HSV-based Oncolytic Viruses
1.2.4 Adenoviruses-based Oncolytic Viruses
1.2.5 Vaccinia Virus-based Oncolytic Viruses
1.2.6 Vesicular Stomatitis Virus-based Oncolytic Viruses
1.2.7 Newcastle Disease Virus-based Oncolytic Viruses
1.3 Global Oncolytic Virus Therapy Market by Application
1.3.1 Overview: Global Oncolytic Virus Therapy Revenue by Application
1.3.2 Melanoma
1.3.3 Prostate Cancer
1.3.4 Breast Cancer
1.3.5 Ovarian Cancer
1.3.6 Others
1.4 Global Oncolytic Virus Therapy Market by Regions
1.4.1 Global Oncolytic Virus Therapy Market Size by Regions
1.4.2 Global Market Size of Oncolytic Virus Therapy (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Oncolytic Virus Therapy Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Oncolytic Virus Therapy Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Oncolytic Virus Therapy Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Oncolytic Virus Therapy Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Oncolytic Virus Therapy Status and Prospect (2015-2025)
2 Company Profiles
2.1 Amgen
2.1.1 Amgen Details
2.1.2 Amgen Major Business
2.1.3 Amgen SWOT Analysis
2.1.4 Amgen Product and Services
2.1.5 Amgen Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.2 SillaJen Biotherapeutics
2.2.1 SillaJen Biotherapeutics Details
2.2.2 SillaJen Biotherapeutics Major Business
2.2.3 SillaJen Biotherapeutics SWOT Analysis
2.2.4 SillaJen Biotherapeutics Product and Services
2.2.5 SillaJen Biotherapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.3 Transgene SA
2.3.1 Transgene SA Details
2.3.2 Transgene SA Major Business
2.3.3 Transgene SA SWOT Analysis
2.3.4 Transgene SA Product and Services
2.3.5 Transgene SA Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.4 Oncolytics Biotech
2.4.1 Oncolytics Biotech Details
2.4.2 Oncolytics Biotech Major Business
2.4.3 Oncolytics Biotech SWOT Analysis
2.4.4 Oncolytics Biotech Product and Services
2.4.5 Oncolytics Biotech Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.5 PsiOxus Therapeutics
2.5.1 PsiOxus Therapeutics Details
2.5.2 PsiOxus Therapeutics Major Business
2.5.3 PsiOxus Therapeutics SWOT Analysis
2.5.4 PsiOxus Therapeutics Product and Services
2.5.5 PsiOxus Therapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.6 Viralytics
2.6.1 Viralytics Details
2.6.2 Viralytics Major Business
2.6.3 Viralytics Product and Services
2.6.4 Viralytics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019) ...
1 Oncolytic Virus Therapy Market Overview
1.1 Product Overview and Scope of Oncolytic Virus Therapy
1.2 Classification of Oncolytic Virus Therapy by Type
1.2.1 Global Oncolytic Virus Therapy Revenue by Type
1.2.2 Global Oncolytic Virus Therapy Revenue Market Share by Type in 2019
1.2.3 HSV-based Oncolytic Viruses
1.2.4 Adenoviruses-based Oncolytic Viruses
1.2.5 Vaccinia Virus-based Oncolytic Viruses
1.2.6 Vesicular Stomatitis Virus-based Oncolytic Viruses
1.2.7 Newcastle Disease Virus-based Oncolytic Viruses
1.3 Global Oncolytic Virus Therapy Market by Application
1.3.1 Overview: Global Oncolytic Virus Therapy Revenue by Application
1.3.2 Melanoma
1.3.3 Prostate Cancer
1.3.4 Breast Cancer
1.3.5 Ovarian Cancer
1.3.6 Others
1.4 Global Oncolytic Virus Therapy Market by Regions
1.4.1 Global Oncolytic Virus Therapy Market Size by Regions
1.4.2 Global Market Size of Oncolytic Virus Therapy (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Oncolytic Virus Therapy Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Oncolytic Virus Therapy Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Oncolytic Virus Therapy Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Oncolytic Virus Therapy Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Oncolytic Virus Therapy Status and Prospect (2015-2025)
2 Company Profiles
2.1 Amgen
2.1.1 Amgen Details
2.1.2 Amgen Major Business
2.1.3 Amgen SWOT Analysis
2.1.4 Amgen Product and Services
2.1.5 Amgen Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.2 SillaJen Biotherapeutics
2.2.1 SillaJen Biotherapeutics Details
2.2.2 SillaJen Biotherapeutics Major Business
2.2.3 SillaJen Biotherapeutics SWOT Analysis
2.2.4 SillaJen Biotherapeutics Product and Services
2.2.5 SillaJen Biotherapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.3 Transgene SA
2.3.1 Transgene SA Details
2.3.2 Transgene SA Major Business
2.3.3 Transgene SA SWOT Analysis
2.3.4 Transgene SA Product and Services
2.3.5 Transgene SA Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.4 Oncolytics Biotech
2.4.1 Oncolytics Biotech Details
2.4.2 Oncolytics Biotech Major Business
2.4.3 Oncolytics Biotech SWOT Analysis
2.4.4 Oncolytics Biotech Product and Services
2.4.5 Oncolytics Biotech Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.5 PsiOxus Therapeutics
2.5.1 PsiOxus Therapeutics Details
2.5.2 PsiOxus Therapeutics Major Business
2.5.3 PsiOxus Therapeutics SWOT Analysis
2.5.4 PsiOxus Therapeutics Product and Services
2.5.5 PsiOxus Therapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.6 Viralytics
2.6.1 Viralytics Details
2.6.2 Viralytics Major Business
2.6.3 Viralytics Product and Services
2.6.4 Viralytics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019) ...
Related Categories :
Healthcare Technology And Services
www.decisiondatabases.com is a online aggregator of market and research database which includes databases, reports and profiles. We have started this portal with a aim to become one stop shop provider for marketing and research data requirements for various sector and country databases.
Main Categories
